-Parties: The Appellants were AbbVie Corporation and AbbVie Biotechnology Ltd.; the Respondent was JAMP Pharma Corporation.

-Subject Matter: This Federal Court of Appeal matter (A-347-23) is an appeal (S.27 – Final) under the Patent Act filed in Toronto on December 15, 2023, by AbbVie Corporation and AbbVie Biotechnology Ltd. against JAMP Pharma Corporation. The appeal was consolidated with file A-348-23, with A-347-23 designated as the lead appeal. The case is ongoing. 

-Date: The hearing was set on September 9, 2026.

-Venue: This was a federal case before the Federal Court of Appeal. 

-Amount: No financial award was specified.